Oliver Lagore Vanvalin Investment Group’s Emerson Electric EMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$153K Buy
+1,397
New +$160K 0.06% 153
2024
Q4
$173K Hold
1,397
0.04% 127
2024
Q3
$153K Hold
1,397
0.04% 139
2024
Q2
$154K Hold
1,397
0.04% 137
2024
Q1
$158K Hold
1,397
0.05% 144
2023
Q4
$136K Hold
1,397
0.05% 130
2023
Q3
$135K Buy
1,397
+997
+249% +$95K 0.05% 139
2023
Q2
$36.2K Hold
400
0.01% 292
2023
Q1
$34.9K Hold
400
0.01% 225
2022
Q4
$38.4K Hold
400
0.02% 205
2022
Q3
$29K Hold
400
0.02% 217
2022
Q2
$32K Hold
400
0.02% 220
2022
Q1
$39K Buy
+400
New +$37.9K 0.03% 192

Other funds holding EMR

Oliver Lagore Vanvalin Investment Group's EMR Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Emerson Electric (EMR) in Q2 2025: 1,397 shares worth $153K. The stake represents 0.06% of the portfolio and ranks #153 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in EMR as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in EMR in Q1 2022 and has held it in 13 quarters since. The position peaked at $173K in Q4 2024. 2,135 funds tracked by Wall St. Rank hold EMR as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 1,397 shares of Emerson Electric worth $153K as of Q2 2025.
  • Emerson Electric was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Emerson Electric made up 0.06% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #153 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Emerson Electric in Q1 2022 and has held it in 13 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Emerson Electric position peaked at $173K in Q4 2024.
  • 2,135 funds tracked by Wall St. Rank held Emerson Electric as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.